Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Share on Pinterest From newly approved medications to promising research on the road to a potential cure, 2022 was a year filled with significant advancements in HIV care and prevention. Natalie ...
The US HIV/AIDS Strategy and Ending the HIV Epidemic (EHE) initiatives aim to reduce HIV transmission by 90% by 2030 through targeted care and prevention initiatives such as the Undetectable = ...
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ T-cells at 24 weeks of therapy predicted the subsequent reduction in the ...
Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher infection ...
Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...
An in-depth look at HIV epidemiology in Mizoram, examining rising infection rates, drug use, trafficking, and public health responses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results